The University of Southampton
University of Southampton Institutional Repository

Human leukocyte immunoglobulin-like receptors in health and disease

Human leukocyte immunoglobulin-like receptors in health and disease
Human leukocyte immunoglobulin-like receptors in health and disease
Human leukocyte immunoglobulin (Ig)-like receptors (LILR) are a family of 11 innate immunomodulatory receptors, primarily expressed on lymphoid and myeloid cells. LILRs are either activating (LILRA) or inhibitory (LILRB) depending on their associated signalling domains (D). With the exception of the soluble LILRA3, LILRAs mediate immune activation, while LILRB1-5 primarily inhibit immune responses and mediate tolerance. Abnormal expression and function of LILRs is associated with a range of pathologies, including immune insufficiency (infection and malignancy) and overt immune responses (autoimmunity and alloresponses), suggesting LILRs may be excellent candidates for targeted immunotherapies. This review will discuss the biology and clinical relevance of this extensive family of immune receptors and will summarise the recent developments in targeting LILRs in disease settings, such as cancer, with an update on the clinical trials investigating the therapeutic targeting of these receptors.
Humans, Immunoglobulins, Immunomodulation, LILR, Leukocytes, Myeloid Cells, Receptors, Immunologic/metabolism, autoimmunity, cancer, immune tolerance, immunomodulation, immunotherapy, infection
1664-3224
Redondo-García, Silvia
97c5a332-37c2-4170-9677-44e030a6ff41
Barritt, Christopher
2a8d8f9c-1856-46b2-9816-4b8c3178fa32
Papagregoriou, Charys
c7b077d1-4274-49c4-b848-f05a23350a30
Yeboah, Muchaala
1a3d6a64-4374-4db5-aa6f-6c9ff7542830
Frendeus, Björn
50bf6a56-176f-4784-932a-21c10e87805b
Cragg, Mark S.
ec97f80e-f3c8-49b7-a960-20dff648b78c
Roghanian, Ali
e2b032c2-60a0-4522-a3d8-56a768792f36
Redondo-García, Silvia
97c5a332-37c2-4170-9677-44e030a6ff41
Barritt, Christopher
2a8d8f9c-1856-46b2-9816-4b8c3178fa32
Papagregoriou, Charys
c7b077d1-4274-49c4-b848-f05a23350a30
Yeboah, Muchaala
1a3d6a64-4374-4db5-aa6f-6c9ff7542830
Frendeus, Björn
50bf6a56-176f-4784-932a-21c10e87805b
Cragg, Mark S.
ec97f80e-f3c8-49b7-a960-20dff648b78c
Roghanian, Ali
e2b032c2-60a0-4522-a3d8-56a768792f36

Redondo-García, Silvia, Barritt, Christopher, Papagregoriou, Charys, Yeboah, Muchaala, Frendeus, Björn, Cragg, Mark S. and Roghanian, Ali (2023) Human leukocyte immunoglobulin-like receptors in health and disease. Frontiers in Immunology, 14, [1282874]. (doi:10.3389/fimmu.2023.1282874).

Record type: Review

Abstract

Human leukocyte immunoglobulin (Ig)-like receptors (LILR) are a family of 11 innate immunomodulatory receptors, primarily expressed on lymphoid and myeloid cells. LILRs are either activating (LILRA) or inhibitory (LILRB) depending on their associated signalling domains (D). With the exception of the soluble LILRA3, LILRAs mediate immune activation, while LILRB1-5 primarily inhibit immune responses and mediate tolerance. Abnormal expression and function of LILRs is associated with a range of pathologies, including immune insufficiency (infection and malignancy) and overt immune responses (autoimmunity and alloresponses), suggesting LILRs may be excellent candidates for targeted immunotherapies. This review will discuss the biology and clinical relevance of this extensive family of immune receptors and will summarise the recent developments in targeting LILRs in disease settings, such as cancer, with an update on the clinical trials investigating the therapeutic targeting of these receptors.

Text
fimmu-14-1282874 - Version of Record
Available under License Creative Commons Attribution.
Download (3MB)

More information

Accepted/In Press date: 20 September 2023
e-pub ahead of print date: 13 November 2023
Published date: 2023
Additional Information: Publisher Copyright: Copyright © 2023 Redondo-García, Barritt, Papagregoriou, Yeboah, Frendeus, Cragg and Roghanian. Copyright © 2023 Redondo-García, Barritt, Papagregoriou, Yeboah, Frendeus, Cragg and Roghanian.
Keywords: Humans, Immunoglobulins, Immunomodulation, LILR, Leukocytes, Myeloid Cells, Receptors, Immunologic/metabolism, autoimmunity, cancer, immune tolerance, immunomodulation, immunotherapy, infection

Identifiers

Local EPrints ID: 484317
URI: http://eprints.soton.ac.uk/id/eprint/484317
ISSN: 1664-3224
PURE UUID: ca5a0e90-e14f-4f4d-8675-d5e0b6cab4e3
ORCID for Silvia Redondo-García: ORCID iD orcid.org/0000-0002-7883-3817
ORCID for Mark S. Cragg: ORCID iD orcid.org/0000-0003-2077-089X
ORCID for Ali Roghanian: ORCID iD orcid.org/0000-0003-1316-4218

Catalogue record

Date deposited: 15 Nov 2023 18:00
Last modified: 21 Mar 2024 03:12

Export record

Altmetrics

Contributors

Author: Silvia Redondo-García ORCID iD
Author: Christopher Barritt
Author: Charys Papagregoriou
Author: Muchaala Yeboah
Author: Björn Frendeus
Author: Mark S. Cragg ORCID iD
Author: Ali Roghanian ORCID iD

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×